Ticker Symbol: DTIL
Precision Biosciences Inc
$9.69 - 20-11-2024 4 p.m. ET
Exchange: NASDAQ
Country:
United States
Currency:
USD
Asset
Type: Common Stock
CIK:0001357874
Company Profile
Precision BioSciences, Inc. is a clinical stage biotechnology company dedicated to improving life (DTIL) with its wholly proprietary ARCUS® genome editing platform. ARCUS is a highly specific and versatile genome editing platform that was designed with therapeutic safety, delivery, and control in mind. Using ARCUS, the Company's pipeline consists of multiple 'off-the-shelf' CAR T immunotherapy clinical candidates and several in vivo gene correction therapy candidates to cure genetic and infectious diseases where no adequate treatments exist.
Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in Biotechnology
Standard Industrial Classification Code (SIC code): 2836
Address: 302 E Pettigrew St Ste A100
Website: precisionbiosciences.com
CEO: Matthew Kane
Tags:
- Biotechnology
- Health Technology
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $0.32
Change:
-$0.01
(
-3.13%)
Days Range: $0.29 - $0.33
Beta: 1.18
52wk. High: $1.70
52wk. Low: $0.28
Ytd. Change -75.20%
50 Day Moving Average: $0.37
200 Day Moving Average: $0.60
Shares Outstanding: 115070517
Valuation
Market Cap: 3.7B
PE Ratio: -0.40
EPS (TTM): -0.7981
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A